Patent intelligence · US
US 11826392
Purification method of fungal cell wall composition
Purification method of fungal cell wall composition
Patent details — US 11826392
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 28, 2023
- Expiration
- Nov 23, 2043
- Applicant
- HONG SHENG PRECISION BIOTECH CO., LTD.
- Claims
- 14
- CPC classes
- A61K, A61K2236/33, A61K2236/39, A61K31/726
Quick answer
US 11826392 (Purification method of fungal cell wall composition) is held by HONG SHENG PRECISION BIOTECH CO., LTD.. Status: granted. Granted Nov 28, 2023. Expires Nov 23, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- HONG SHENG PRECISION BIOTECH CO., LTD.
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K2236/33, A61K2236/39, A61K31/726, A61K36/074
More from HONG SHENG PRECISION BIOTECH CO., LTD.
Related pharmaceutical patents in our USPTO index.
-
US 12419920
Bifidobacterium longum NCIMB 41676
granted -
US 12410418
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 12351839
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted -
US 12344676
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 12336835
Neuromodulation to target glucose transporter and/or incretin pathways
granted -
US 12232492
Disinfection of bacteriophages products using supercritical carbon dioxide
granted -
US 12233135
Therapeutic constructs for treating cancer
granted -
US 12180463
Lactobacillus reuteri
granted
Frequently asked questions
What is US patent 11826392?
US 11826392 (Purification method of fungal cell wall composition) is held by HONG SHENG PRECISION BIOTECH CO., LTD.. Status: granted. Granted Nov 28, 2023. Expires Nov 23, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11826392?
HONG SHENG PRECISION BIOTECH CO., LTD. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 158 pharmaceutical patents for this assignee.
When does US 11826392 expire?
Our index shows an expiration date of Nov 23, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.